BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8192182)

  • 1. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR; Lucore CL; Eisenberg PR
    Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
    Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
    Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
    [No Abstract]   [Full Text] [Related]  

  • 3. Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism.
    Jude B; Amrouni N; Deguine I; Marey A; Asseman P; Watel A; Thery C; Marache P; Cosson A
    Thromb Res; 1992 Feb; 65(3):457-62. PubMed ID: 1631808
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
    Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J
    Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic therapy for pulmonary thromboembolism].
    Pankov KS
    Klin Med (Mosk); 2004; 82(10):4-8. PubMed ID: 15584590
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinolysis in pulmonary embolism].
    Thabut G; Jebrak G
    Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of pulmonary embolism].
    Matthias FR; Schöndorf TH
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):38-46. PubMed ID: 2427413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does thrombolytic treatment modify the prognosis of pulmonary embolism?].
    Sasahara AA; Sharma GV; McIntyre KM; Cella G
    Haemostasis; 1986; 16 Suppl 4():54-61. PubMed ID: 3770557
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism.
    Griguer P; Charbonnier B; Latour F; Fauchier JP; Brochier M
    Angiology; 1979 Jan; 30(1):1-12. PubMed ID: 426316
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism].
    Peng K; Wang C; Pang BS; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):596-9. PubMed ID: 16207425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial.
    Marini C; Di Ricco G; Rossi G; Rindi M; Palla R; Giuntini C
    Respiration; 1988; 54(3):162-73. PubMed ID: 3073463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
    Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
    Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic treatment of pulmonary embolism.
    Palevsky HI; Raffin TA
    West J Med; 1992 Aug; 157(2):171. PubMed ID: 1441471
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator.
    Goldhaber SZ; Markis JE; Kessler CM; Meyerovitz MF; Kim D; Vauchan DE; Selwyn AP; Loscalzo J; Dawley DL; Sharma GV
    Semin Thromb Hemost; 1987 Apr; 13(2):171-7. PubMed ID: 3114885
    [No Abstract]   [Full Text] [Related]  

  • 17. Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study.
    Bell WR
    Thromb Haemost; 1976 Feb; 35(1):57-69. PubMed ID: 785689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolism.
    Tebbe U; Seifried E; Carlsson J; Tanswell P
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):475-80. PubMed ID: 1420824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiorespiratory efficacy of thrombolytic therapy in acute massive pulmonary embolism: identification of predictive factors.
    Michard F; Meyer G; Wysocki M; Diehl JL; Mercat A; Sors H
    Eur Respir J; 1999 Mar; 13(3):610-5. PubMed ID: 10232435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.